Expression of the inflammasome component NLRP3 and the pro-inflammatory cytokine IL-1β is increased in samples from CRMO patients when compared to LHC patients or healthy controls. This evidence concerns the gene IL1B and chronic recurrent multifocal osteomyelitis.